Citadel Advisors »

China Sxt Pharmaceuticals In shares owned by Citadel Advisors

Quarter-by-quarter ownership of China Sxt Pharmaceuticals In (SXTC) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in China Sxt Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including China Sxt Pharmaceuticals In held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in China Sxt Pharmaceuticals In by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $78k 49k 1.59

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding China Sxt Pharmaceuticals In

Invesco
Geode Capital Management
Citadel Advisors
Renaissance Technologies
Virtu Financial
Hrt Financial
Two Sigma Securities
Tower Research Capital
UBS Group
State of Wyoming

View all funds holding China Sxt Pharmaceuticals In